Technical References
( Dendritic Cells )
721. HUMAN INTESTINAL DENDRITIC CELLS DECREASE CYTOKINE RELEASE AGAINST SALMONELLA INFECTION IN THE PRESENCE OF LACTOBACILLUS PARACASEI UPON TLR ACTIVATION.
Bermudez-Brito1, M., Munoz-Quezada1, S., Gomez-Llorente1, C., Matencio2, E., Bernal2, M.J., Romero2, F., Gil1, A. 1Institute of Nutrition and Food Technology Jose Mataix, Biomedical Research Centre, Department of Biochemistry and Molecular Biology II, University of Granada, Granada, Spain, 2Hero Institute for Infant Nutrition, Hero Spain, Alcantarilla, Murcia, Spain. PLOS ONE, 7, 8, (2012).
675. ASSURING SAFETY WITHOUT ANIMAL TESTING: DEVELOPMENT OF MECHANISTIC UNDERSTANDING OF DENDRITIC CELL ACTIVATION RESPONSE TO CHEMICAL SENSITISERS.
Jones1, P., White1, A., Fletcher1, S., Castle1, K., Ayehunie2, S., and Lim3, F-L. 1Safety and Environmental Assurance Centre, Unilever, Colworth Science Park, Sharnbrook, Bedford, MK44 1LQ, UK, 2MatTek Corporation, 200 Homer Avenue, Ashland, MA, 01721, USA, 3Discover, Unilever, Colworth Science Park, Sharnbrook, Bedford, MK44 1LQ, UK Presented at 13th Annual Congress of EUSAAT, Linz, Austia, 2010.
647. IN VITRO MODEL FOR IMMUNOTOXICITY: SURFACE MARKER EXPRESSION AND CYTOKINE RELEASE IN NORMAL HUMAN DENDRITIC CELLS (DC-100).
Hunter, A., Landry, T., Klausner, M., and Ayehunie, S. MatTek Corporation, Ashland, MA, USA. Presented at SOT 2011, Abstract #652.
646. PLASMACYTOID DENDRITIC CELL-BASED ASSAY AS AN IN VITRO ALTERNATIVE FOR CHEMICAL ALLERGENICITY SCREENING.
Ayehunie, S., Child, M., Spratt, M., Klausner, M. MatTek Corporation, Ashland, MA, USA. Presented at SOT 2011 Abstract # 87.
568. EVALUATION OF PLASMACYTOID DENDRITIC CELL-BASED ASSAY TO DETERMINE CHEMICAL ALLERGENICITY.
Ayehunie, S., Hayden, P., Kaluzhny, Y., Child, M., Snell, M., and Klausner, M. MatTek Corporation, Ashland, MA. Presented at 49th Annual SOT Meeting, Salt Lake City, Utah (2010).
529. A PLASMACYTOID DENDRITIC CELL (CD123+/CD11c−) BASED ASSAY SYSTEM TO PREDICT CONTACT ALLERGENICITY OF CHEMICALS.
Ayehunie, S., Snell, M., Child, M., Klausner, M. MatTek Corporation, Ashland, MA 01721, United States. Toxicology (2009), doi:10.1016/j.tox.2009.07.021.
502. GENE EXPRESSION ANALYSIS OF DENDRITIC/LANGERHANS CELLS AND LANGERHANS CELL HISTIOCYTOSIS.
Rust1, R., Kluiver1, J., Visser1, L., Harms1, G., Blokzijl1, T., Kamps2, W., Poppema1, S., and van den Berg1, A. 1Department of Pathology and Laboratory Medicine, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands. 2Department of Pediatric Oncology, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands. J Pathol, 209, 474–483 (2006).
484. CD137/CD137L EXPRESSION AND SIGNALING IN IN VITRO MODELS OF HUMAN AIRWAY EPITHELIUM, DENDRITIC CELLS AND T-CELLS.
Hayden, P.J., Ayehunie, S., Spiller, E., Snell, M., Jackson, G.R. Jr., and Klausner, M. MatTek Corporation, Ashland, MA. Amer. J. of Respiratory and Critical Care Medicine, Vol 177 (Abstracts Issue): pA72 (2008).
477. COLCHICINE PROMOTES ANTIGEN CROSS-PRESENTATION BY MURINE DENDRITIC CELLS.
Mizumoto1,2, N., Tanaka1,2, H., Matsushima1,2, H., Vishwanath1,2, M., and Takashima1,2, A. 1,2Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. J. of Invest. Dematol., 127, 1543-1546, (2007).
475. NOREPINEPHRINE MODULATES HUMAN DENDRITIC CELL ACTIVATION BY ALTERING CYTOKINE RELEASE.
Goyarts1, E., Matsui1, M., Mammone1, T., Bender2, A.M., Wagner3, J.A., Maes1, D., and Granstein2, R.D. 1Clinique Laboratories, Melville, NY, USA; 2Department of Dermatology, Weill Medical College of Cornell University, New York, NY, USA; 3Department of Neurology & Neuroscience, Weill Medical College of Cornell University, New York, NY, USA. Experimental Dermatology, 17, 188-196, (2007).
451. ACTIVATED CD34-DERIVED LANGERHANS CELLS MEDIATE TRANSINFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS.
Fahrbach1, K.M., Barry1,2, S.M., Ayehunie3, S., Lamore3, S., Klausner3, M. and Hope1, T.J. 1Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611; 2Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612; and 3MatTek Corporation, 200 Homer Avenue, Ashland, Massachusetts 01721. J. of Virology, 81, (13), 6858-6868, (2007).
449. PLASMACYTOID DENDRITIC CELLS AS A TOOL FOR TESTING ALLERGENICITY OF CHEMICALS.
Ayehunie, S., Snell, M., Hayden, P.J., Klausner, M., and Sheasgreen, J. MatTek Corporation, Ashland, MA 01721. Society of Toxicology 46th Annual Meeting, Charlotte, NC, (2007). Abstract #1146. The Toxicologist, 96, 1, 238 (2007).
440. IN VITRO DERIVED DENDRITIC CELLS TRANS-INFECT CD4 T CELLS PRIMARILY WITH SURFACE-BOUND HIV-1 VIRIONS.
Cavrois1, M., Neidleman1, J., Kreisberg1,2, J.F., Greene1,2,3, W.C. 1Gladstone Institute of Virology and Immunology, University of California San Francisco, San Francisco, California, United States of America, 2Department of Medicine, University of California San Francisco, San Francisco, California, United States of America, 3Department of Microbiology and Immunology, University of California San Francisco, San Francisco, California, United States of America. PLoS Pathogens, 3, (1), 0038-0045, (2007).
425. LANGERHANS CELLS RELEASE PROSTAGLANDIN D2 IN RESPONSE TO NICOTINIC ACID.
Maciejewski-Lenoir, D., Richman, J., Hakak, Y., Gaidarov, I., Behan, D., and Connolly, D. Arena Pharmaceuticals Inc., San Diego, CA. Journal of Investigative Dermatology, 126, 2637-2646, (2006).
408. THE USE OF PLASMACYTOID DENDRITIC CELLS FOR ALLERGENICITY SCREENING OF CHEMICALS.
Ayehunie, S., Lamore, S., Snell, M., Klausner, M., Sheasgreen, J. MatTek Corporation, Ashland, MA, USA. Presented at The American Association of Immunologists, Boston, MA, May 12-16 (2006).
407. NOREPINEPHRINE INHIBITS LANGERHANS CELL ACTIVATION BY ALTERING CYTOKINE RELEASE.
Goyarts, E., Bender, A.M., Matsui, M., Mammone, T., Maes, D. Estee Lauder Research Laboratories, Melville, NY and Dept. of Dermatology, Weill Medical College of Cornell University. Presented at the Society for Investigative Dermatology Annual Meeting, Philadelphia, PA, May 3-6 (2006).
398. GENETICALLY-ENGINEERED IL-10-SECRETING KERATINOCYTES CONDITION LANGERHANS CELLS TOWARDS A TOLERAGENIC PHENOTYPE.
Prakasam, S., Jotwani, R., Taichman, L., Cutler, C.W. State University of New York - SUNY - Stony Brook, USA. Presented at the International Association for Dental Research, Brisbane Australia, June 28-July 1, (2006).
382. LARGE SCALE PRODUCTION OF LANGERHANS CELLS/PLASMACYTOID DENDRITIC CELLS FOR ALLERGENICITY STUDIES AND IN VITRO TISSUE ENGINEERING.
Ayehunie, S., Lamore, S., Snell, M., Klausner, M., and Sheasgreen, J. MatTek Corporation, Ashland, MA. (USA). Presented at 5th World Congress, Berlin, Germany, August, (2005). Presented at 9th International Workshop on Langerhans Cells, Madeira, Portugal (2005).
342. GENERATION OF LONG LIVED DENDRITIC CELLS FOR ALLERGENICITY STUDIES AND MUCOSAL TISSUE ENGINEERING.
Ayehunie, S., Lamore, S., Lappen, R., Bellavance, K., Cannon, C., Klausner, M., and Sheasgreen, J. MatTek Corporation, 200 Homer Avenue, Ashland, MA 01721. Eighth International Symposium on Dendritic Cells, 17-21 October 2004.
340. LARGE SCALE PREPARATION OF DENDRITIC CELLS FROM CD34+ PROGENITOR CELLS FOR IMMUNOLOGICAL STUDIES.
Ayehunie, S., Lamore, S., Lappen, R., Bellavance, K., Klausner, M., and Sheasgreen, J. MatTek Corporation, 200 Homer Avenue, Ashland, MA 01721. Presented at 12th Int’l Congress of Immunology, Montreal, Canada (2004).
324. CHARACTERIZATION AND EVALUATION OF CD34+ GENERATED LANGERHANS CELLS FOR TISSUE ENGINEERING.
Ayehunie, S., Lamore, S., Bellavance, K., Lappen, R., Klausner, M., and Sheasgreen, J. MatTek Corporation, 200 Homer Avenue, Ashland, MA. J. Invest. Dermatol., 122, (3), A129, Abstract #773, (2004).
322. NORMAL HUMAN DENDRITIC CELLS: A TOOL TO STUDY ALLERGIC AND IMMUNOLOGICAL REACTIONS IN VITRO.
Ayehunie, S., Lamore, S., Bellavance, K., Lappen, R., Sheasgreen, J., Hayden, P., and Klausner M. MatTek Corporation, Ashland, MA. Poster Presented at the Society of Toxicology Annual Meeting, Baltimore, MD., March 21-25, (2004). The Toxicologist, 78, S1, 135 (2004).
311. HARVEST, PROLIFERATION, AND FUNCTIONAL TESTING OF HUMAN DENDRITIC CELLS.
Ayehunie, S., Lamore, S., Bellavance, K., and Klausner, M. MatTek Corporation, Ashland, MA. Poster presented at the American Association of Pharmaceutical Scientists (AAPS), Salt Lake City, UT, October 26-30, (2003).
305. IMPROVED METHOD FOR THE GENERATION OF LONG LIVED AND FUNCTIONALLY ACTIVE DENDRITIC/LANGERHANS CELLS FROM CD34+ PROGENITOR CELLS.
Seyoum Ayehunie, Sarah Lamore, Kristen Bellavance, John Sheasgreen, and Mitchell Klausner. MatTek Corporation, Ashland, MA. Presented at LC Symposium-Tokyo (2003).
295. IMPROVED RESPONSIVENESS OF LANGERHANS / DENDRITIC CELLS TO ALLERGENS.
Ayehunie, S., Lamore, S., Lappen, R., Bellavance, K., Hayden, P., Sheasgreen, J., and Klausner, M. MatTek Corp., Ashland, MA. J. Invest. Dermatol., 121, (1), Abstract #886, (2003).
www.MatTek.co.kr
